Stocklytics Platform
Quest Diagnostics
DGX54
$170.39arrow_drop_down0.14%-$0.24
S&P500
DGX54

$170.39

arrow_drop_down0.14%

Performance History

Chart placeholder
no data available for key stats

There's no data available for key stats

no data available for ratios/profitability stats

There's no data available for ratios/profitability stats

Score Breakdown

Welcome to Stocklytics

Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.

Analyst Forecast

Period: Next 12 Months

Analyst Ratings

Correlated Companies

Price$788.17
Perf. (24h)arrow_drop_down0.11%-$0.91
Market Cap$708.73B
Price$538.05
Perf. (24h)arrow_drop_down0.45%-$2.44
Market Cap$494.34B
Price$159.39
Perf. (24h)arrow_drop_down0.39%-$0.62
Market Cap$397.30B
Price$199.86
Perf. (24h)arrow_drop_down0.88%-$1.77
Market Cap$356.69B

About Quest Diagnostics (DGX)

Quest Diagnostics Inc (DGX) is a leading provider of diagnostic testing, information, and services. With a market cap of over $14 billion, the company operates a network of laboratories and service centers throughout the United States. Quest Diagnostics offers a wide range of diagnostic testing services, including routine and specialty testing, such as molecular and genetic testing, as well as advanced diagnostic information technology solutions.
The stock price history of Quest Diagnostics Inc (DGX) has shown steady growth over the years. The company has consistently delivered strong financial performance, with increasing revenues and earnings. The stock has been a reliable performer, providing investors with consistent returns. The PEG ratio, which measures the stock's valuation relative to its growth prospects, is favorable for DGX, indicating that it may be undervalued compared to its earnings growth potential.
Sector
Healthcare
Industry
Diagnostics & Research
CEO
Mr. James E. Davis
Headquarters
Secaucus
Employees
40000
Exchange
NYSE
add Quest Diagnostics  to watchlist

Keep an eye on Quest Diagnostics

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

search
help

What is Quest Diagnostics 's (DGX) price per share?

The current price per share for Quest Diagnostics (DGX) is $170.39. The stock has seen a price change of -$0.24 recently, indicating a -0.14% change. This reflects the stock's recent market performance and investor sentiment.
help

What is the 52-week high and low for Quest Diagnostics (DGX)?

For Quest Diagnostics (DGX), the 52-week high is $184.01, which is 7.99% from the current price. The 52-week low is $120.1, the current price is 41.87% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.
help

Is Quest Diagnostics (DGX) a growth stock?

Quest Diagnostics (DGX) has shown an average price growth of -1.65% over the past three years. It has received a score of 66 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying Quest Diagnostics as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.
help

What is Quest Diagnostics (DGX) stock price performance year to date (YTD)?

As of the latest data, Quest Diagnostics (DGX) has a year-to-date price change of 12.95%. Over the past month, the stock has experienced a price change of -3.71%. Over the last three months, the change has been 12.16%. Over the past six months, the figure is 12%. Looking at a longer horizon, the five-year price change stands at 132.33%.
help

Is Quest Diagnostics (DGX) a profitable company?

Quest Diagnostics (DGX) has a net income of $921M, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of 32.86% indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of 14.04% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at $9.87B, with a revenue growth rate of 6.7%, providing insight into the company's sales performance and growth. The gross profit is $3.24B. Operating income is noted at $1.35B. Furthermore, the EBITDA is $1.89B.
help

What is the market capitalization of Quest Diagnostics (DGX)?

Quest Diagnostics (DGX) has a market capitalization of $18.94B. The average daily trading volume is 170.45, indicating the stock's liquidity and investor engagement.

Take Your Investments to a Whole New Level